Cervical neoplasia, brachytherapy, radiation effects, pathologic constriction, dyspareunia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Female patients; aged between 18 and 65 years; in treatment for locally advanced cervical cancer (according to FIGO staging); who will undergo brachytherapy; and those who agreed to participate in the study
Exclusion criteria
Exclusion criteria: Patients with cognitive deficits, with distante metastases, with collagen diseases, pregnant women, relapsing disease, residual disease reported in writing after the end of brachytherapy, submitted to a previous hysterectomy (partial or total), active condition of Venous Deep Thrombosis, cardiopulmonary disorders that limit ADLs, pacemaker patients, acute urogenital infection, genital prolapse, inability to stand up, phlebitis, embolism, advanced osteoporosis, epileptics, and those that lack any of the assessment steps.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in vaginal dimensions, through measurement of the depth, anteroposterior and lateral-lateral diameters of the vagina | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of sexual function, evaluated through the Female Sexual Function Index (FSFI)questionnaire Improvement in quality of life, evaluated through the Functional Assessment of Cancer Therapy-cervix (FACT-Cx. Improvement in platelet-lymphocyte índex. Improvement in fatigue complaints | — |
Countries
Brazil
Contacts
Hospital Universitário Pedro Ernesto